The trademark application ADARIV was filed by ADAMED PHARMA S.A., a corporation established under the laws of the Republic of Poland (the "Applicant"). The application was published for oppositions on March 7, 2021, and it was registered by office on June 14, 2021 without any oppositions.
The application was filed in Polish (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on August 11, 2021. Appointment and Replacement of representative of the trademark registration was recorded on December 18, 2023.